FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to neurology and psychiatry, and concerns treating cognitive disorders. That is ensured by introduction of a human albumin drug in the form of a solution for plasma exchange (plasmapheresis).
EFFECT: administration of said agent provides effective treatment of cognitive disorders ensured by extent of the hippocampus regardless of blood beta-amyloid concentration.
5 cl, 10 dwg, 2 tbl
Authors
Dates
2011-03-27—Published
2008-10-17—Filed